DE69609201T2 - 21-[2-oxo-tetrahydrofuran]-thio pregnan derivative, ein verfahren zu ihrer herstellung und pharmazeutische präparate davon - Google Patents
21-[2-oxo-tetrahydrofuran]-thio pregnan derivative, ein verfahren zu ihrer herstellung und pharmazeutische präparate davonInfo
- Publication number
- DE69609201T2 DE69609201T2 DE69609201T DE69609201T DE69609201T2 DE 69609201 T2 DE69609201 T2 DE 69609201T2 DE 69609201 T DE69609201 T DE 69609201T DE 69609201 T DE69609201 T DE 69609201T DE 69609201 T2 DE69609201 T2 DE 69609201T2
- Authority
- DE
- Germany
- Prior art keywords
- pct
- thio
- oxo
- tetrahydrofuran
- production
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
- C07J31/006—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
- C07J71/0005—Oxygen-containing hetero ring
- C07J71/0026—Oxygen-containing hetero ring cyclic ketals
- C07J71/0031—Oxygen-containing hetero ring cyclic ketals at positions 16, 17
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Rheumatology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9526630.0A GB9526630D0 (en) | 1995-12-29 | 1995-12-29 | Compounds |
GBGB9613036.4A GB9613036D0 (en) | 1996-06-21 | 1996-06-21 | Compounds |
PCT/GB1996/003153 WO1997024367A1 (en) | 1995-12-29 | 1996-12-19 | 21-(2-oxo-tetrahydrofuran)-thio pregnane derivatives, a process for their production and pharmaceutical compositions containing them |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69609201D1 DE69609201D1 (de) | 2000-08-10 |
DE69609201T2 true DE69609201T2 (de) | 2001-03-01 |
Family
ID=26308399
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69609201T Expired - Fee Related DE69609201T2 (de) | 1995-12-29 | 1996-12-19 | 21-[2-oxo-tetrahydrofuran]-thio pregnan derivative, ein verfahren zu ihrer herstellung und pharmazeutische präparate davon |
Country Status (12)
Country | Link |
---|---|
US (1) | US6013244A (de) |
EP (1) | EP0876393B1 (de) |
JP (1) | JP2947945B2 (de) |
AT (1) | ATE194357T1 (de) |
AU (1) | AU1200097A (de) |
DE (1) | DE69609201T2 (de) |
DK (1) | DK0876393T3 (de) |
ES (1) | ES2150151T3 (de) |
GR (1) | GR3034563T3 (de) |
PT (1) | PT876393E (de) |
SI (1) | SI0876393T1 (de) |
WO (1) | WO1997024367A1 (de) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE260931T1 (de) * | 1997-06-30 | 2004-03-15 | Glaxo Group Ltd | Verfahren zur identifizierung von verbindungen mit verminderter systemischer aktivität |
AU2003263717A1 (en) * | 2002-09-25 | 2004-04-19 | Astrazeneca Ab | A COMBINATION OF A LONG-ACTING Beta2-AGONIST AND A GLUCOCORTICOSTEROID IN THE TREATMENT OF FIBROTIC DISEASES |
WO2008124145A1 (en) * | 2007-04-05 | 2008-10-16 | Government Of The U.S.A., As Represented By The Secretary, Department Of Health And Human Services | Steroid compounds, compositions, and methods of treatment |
CL2008003802A1 (es) * | 2007-12-21 | 2010-02-19 | Schering Corp | Compuestos derivados de tioeteres c-21, agonistas del receptor de glucocorticoide; composicion farmaceutica; y uso para el tratamiento o profilaxis de una enfermedad o afeccion inmune, autoinmune o inflamatoria, tales como artritis reumatoide y esclerosis multiple. |
AU2010260177A1 (en) | 2009-06-16 | 2011-12-15 | Merck Sharp & Dohme Corp. | Novel [3,2-c] heteroaryl steroids as glucocorticoid receptor agonists, compositions and uses thereof |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5420120A (en) * | 1993-12-17 | 1995-05-30 | Alcon Laboratories, Inc. | Anti-inflammatory glucocorticoid compounds for topical ophthalmic use |
-
1996
- 1996-12-19 DE DE69609201T patent/DE69609201T2/de not_active Expired - Fee Related
- 1996-12-19 EP EP96943204A patent/EP0876393B1/de not_active Expired - Lifetime
- 1996-12-19 SI SI9630233T patent/SI0876393T1/xx unknown
- 1996-12-19 PT PT96943204T patent/PT876393E/pt unknown
- 1996-12-19 AU AU12000/97A patent/AU1200097A/en not_active Abandoned
- 1996-12-19 US US09/091,749 patent/US6013244A/en not_active Expired - Fee Related
- 1996-12-19 WO PCT/GB1996/003153 patent/WO1997024367A1/en active IP Right Grant
- 1996-12-19 AT AT96943204T patent/ATE194357T1/de not_active IP Right Cessation
- 1996-12-19 DK DK96943204T patent/DK0876393T3/da active
- 1996-12-19 ES ES96943204T patent/ES2150151T3/es not_active Expired - Lifetime
- 1996-12-19 JP JP9524096A patent/JP2947945B2/ja not_active Expired - Fee Related
-
2000
- 2000-10-04 GR GR20000402253T patent/GR3034563T3/el not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
PT876393E (pt) | 2000-12-29 |
US6013244A (en) | 2000-01-11 |
AU1200097A (en) | 1997-07-28 |
JP2947945B2 (ja) | 1999-09-13 |
EP0876393A1 (de) | 1998-11-11 |
EP0876393B1 (de) | 2000-07-05 |
WO1997024367A1 (en) | 1997-07-10 |
ATE194357T1 (de) | 2000-07-15 |
GR3034563T3 (en) | 2001-01-31 |
DE69609201D1 (de) | 2000-08-10 |
ES2150151T3 (es) | 2000-11-16 |
DK0876393T3 (da) | 2000-11-06 |
SI0876393T1 (en) | 2000-12-31 |
JPH11501676A (ja) | 1999-02-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX9805181A (es) | Derivados de lactona a partir de derivados de 17.beta- carboxi, carbotio y amida androstano. | |
BG100946A (en) | New amino acid derivatives, method for their preparation and pharmaceutical compositions containing them | |
ATE208772T1 (de) | Pharmacologisch wirksame pyridinderivate und verfahren zu deren herstellung | |
DE69425671D1 (de) | Glucosamin-disaccharide, verfahren zu deren herstellung, pharmazeutische präparate davon und ihre verwendung | |
ATE219499T1 (de) | Lipopeptid-derivate, verfahren zu ihrer herstellung und ihre verwendung | |
ATE220681T1 (de) | Wasserlösliche camptothecin-derivate, verfahren zu deren herstellung und deren verwendung als antitumor-mittel | |
ATE145649T1 (de) | Kardioaktive 17-aryl und 17-heterozyklyl-14 beta- 5alpha-androstane, androstene und androstadiene, ein verfahren zu ihrer herstellung und pharmazeutische präperate davon | |
DE59409880D1 (de) | Methylphosphonsäureester, verfahren zu deren herstellung und deren verwendung | |
ATE264107T1 (de) | Cyclooxygenaseinhibitor und salze von amidinderivaten, verfahren zu deren herstellung, deren verwendung als arzneiwirkstoffe sowie diese salze enthaltende arzneimittel | |
DE69838146D1 (de) | Androgene steroidderivate und ein verfahren zur herstellung und verwendung derselben | |
DE69523622T2 (de) | Diastereomerenreine 3-oxo und 3-thioxo-4-aza-androstanderivate und ihre verwendung als antiandrogene | |
ATE270665T1 (de) | Diphenyl-substituierte 5-ring-heterocyclen, verfahren zu ihrer herstellung sowie deren verwendung als arzneimittel | |
ATE154031T1 (de) | 8-en-19, 11 beta-überbrückte steroide, deren herstellung und diese enthaltende pharmazeutische präparate | |
DE69609201T2 (de) | 21-[2-oxo-tetrahydrofuran]-thio pregnan derivative, ein verfahren zu ihrer herstellung und pharmazeutische präparate davon | |
ATE195529T1 (de) | 17beta-(2-oxo-tetrahydrofuran-4-yl)-thio- androstane derivate (17beta-(gamma-buttersäure- lacton)-thio derivate) zur behandlung von entzündungen, pharmazeutische präparate davon und ein verfahren zu ihrer herstellung | |
DE59607683D1 (de) | Neue borneolderivate, verfahren zu ihrer herstellung und ihre pharmazeutische verwendung | |
DE59307133D1 (de) | Gestagen wirksame 19,11-überbrückte 4-estrene | |
DE59507531D1 (de) | Cyclohexanon-derivate, verfahren zu deren herstellung und zwischenprodukte des verfahrens | |
AP1579A (en) | Novel 17-Halogenated 19-nor steroids, method and intermediates for preparing same, use as medicines and pharmaceutical compositions containing same. | |
ATE223430T1 (de) | 11.beta.-substituierte steroide, verfahren zu ihrer herstellung sowie zwischenprodukte davon, ihre verwendung als medikamente und pharmazeutische zusammensetzungen davon | |
DE69215511T2 (de) | Gem-diphosphonsäure-nitrosocarbamoylderivate, verfahren zu deren herstellung und sie enthaltende pharmazeutische zubereitungen | |
ATE141593T1 (de) | Leukotrien-b 4?-derivative, verfahren zu ihrer herstellung und arzneimittel | |
DE69500670T2 (de) | Acetaldehyd-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition | ||
8339 | Ceased/non-payment of the annual fee |